Skip to main content
SpringerLink
Log in

Ovarian Cancer

  • Chapter
PET-CT

  • 893 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Cho SM, Ha HK, Byun JY, et al. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer. AJR 2002;179:391–395.

    PubMed  Google Scholar 

  2. Kubik-Huch RA, et al. Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma. Eur Radiol 2000;10:761–767.

    Google Scholar 

  3. Nakamoto Y. Clinical value of positron emission tomography with FDG for recurrent ovarian cancer. AJR Am J Roentgenol 2001;176:1449–1454.

    PubMed  Google Scholar 

  4. Torizuka T, Nobezawa S, Kanno T, et al. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose. Eur J Nucl Med Mol Imag 2002;29(6):797–803.

    Google Scholar 

  5. Turlakow A, Yeung HW, Salmon AS, Macapinlac HA, Larson SM. Peritoneal carcinomatosis: role of 18F-FDG-PET. J Nucl Med 2003;44:1407–1412.

    PubMed  Google Scholar 

  6. Yen RF, Sun SS, Shen YY, Changlai SP, Kao A. Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer. Anticancer Res 2001;21(5):3691–3694.

    PubMed  Google Scholar 

  7. Wang PH, Liu RS, Li YF, Ng HT, Yuan CC. Whole-body PET with (Fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report. Gynecol Oncol 2000;44:775–778.

    Google Scholar 

  8. Zimny M, Siggelkow W, Schroder W, et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 2001;83:310–315.

    Article  PubMed  Google Scholar 

Download references

Authors
  1. Hossein Jadvar
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. PET Imaging Science Center, University of Southern California, Los Angeles, California, USA

    Peter S. Conti MD, PhD, FACNP, FACR (Professor of Radiology, Clinical Pharmacy & Biomedical Engineering, Director) & Daniel K. Cham MD, MS (Clinical Research Fellow) (Professor of Radiology, Clinical Pharmacy & Biomedical Engineering, Director) &  (Clinical Research Fellow)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Jadvar, H. (2005). Ovarian Cancer. In: Conti, P.S., Cham, D.K. (eds) PET-CT. Springer, New York, NY. https://doi.org/10.1007/0-387-27044-2_24

Download citation

  • DOI: https://doi.org/10.1007/0-387-27044-2_24

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-20858-9

  • Online ISBN: 978-0-387-27044-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation